BioHealth News Archive
Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage
The Johns Hopkins University researchers behind two of Baltimore's most successful biotech firms have founded a new company that has now raised $56 million…
Read MoreNew UMD biotech campus to open in Montgomery County in 2023
The University of Maryland is partnering with Montgomery County to develop a new biotech campus near the North Bethesda Metro Station that will open…
Read MoreEmmes Launches Cell and Gene Therapy Center
Decades of Experience and Emerging Opportunities Led to its Creation ROCKVILLE, Md., Dec. 8, 2022 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization…
Read MoreUnited Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today announced that the company…
Read MoreEmergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray
Emergent’s supplemental new drug application is the first prescription-to-over-the-counter switch application in history to be granted Priority Review by the FDA. NARCAN® (naloxone HCI)…
Read MoreDC Inno – Tech transfer program’s mission: Nurture tech-related businesses and retain “highly trained workforce”
University of Maryland College Park (UMCP) graduates are some of the most sought-after graduates in the country – Maryland is the No. 1 state…
Read MoreWashingon D.C.’s Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study in the Treatment of Acute Performance Anxiety
WASHINGTON, Dec. 2, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765, a novel small molecule…
Read MoreLife depends on this Molecular “Engine” – LinkedIn
3D Model of ATP Synthase - molecular motor (enzyme) that powers cells, generating chemical energy in the form of ATP molecules. The 1997 Nobel…
Read MorePlease Join Us: The Midterms Are Over: Implications for Federal Healthcare and Life Sciences Policy (Tuesday, December 6, 2022 | 1:30 p.m. – 2:30 p.m. ET)
Join Venable’s Ari J. Markenson, Ilisa Halpern Paul, and Joshua Raymond in a discussion of the implications for national healthcare and life sciences policy…
Read MoreFrederick Maryland Launches Next Biotech Bootcamp and Announces New Program Partner
Maryland Manufacturing Extension Partnership joins City/County consortium to expand third Biotech Bootcamp in Frederick FREDERICK, MD. (PRWEB) DECEMBER 01, 2022 Following the completion of two…
Read MoreStockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi
A year marked mostly by biopharma mergers and acquisitions (M&A) in the hundreds of millions of dollars could end with a blockbuster, depending how…
Read MoreUseful Stats: Initial Public Offering (IPO) totals and trends from fiscal years 2019-2022 | SSTI
Over the past four fiscal years, there have been 1,977 initial public offerings (IPOs) completed by companies headquartered in the U.S., according to PitchBook,…
Read MoreUnited Therapeutics CEO Martine Rothblatt Aims to Print Organs
After creating the satellite-radio industry and developing a drug for her daughter's serious disease, Martine Rothblatt is leading her biotech to test another boundary…
Read MoreTherapeutic Developments and Innovative Strategies in Oncology: An Expert Discussion
Cancer continues to be a leading cause of mortality worldwide, accounting for nearly 10 million deaths in 2020. Alongside growing incidence rates each year,…
Read MoreOUR QUANTUM FUTURE: SOME ASSEMBLY REQUIRED A COLLABORATIVE APPROACH FOR ETHICS, POLICY, AND STANDARDS — Quantum World Congress
There is a new revolution of technology emerging based on the understanding of sub-atomic physics: quantum. This revolution leverages advanced scientific understanding and engineering…
Read More